The prospects of PGs in postconceptional therapy.
D000028:Abortion, Induced; D000032:Abortion, Therapeutic; D000200:Action Potentials; D000653:Amniotic Fluid; D000818:Animals; D003338:Corpus Luteum / Q000502:physiology; D005260:Female; D006801:Humans; D007267:Injections; D007275:Injections, Intravenous; D007751:Labor, Induced; D008026:Ligation; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D010053:Ovary / Q000187:drug effects; D011247:Pregnancy; D011374:Progesterone / Q000097:blood; D011453:Prostaglandins / Q000008:administration & dosage / Q000096:biosynthesis / Q000494:pharmacology / Q000627:therapeutic use*; D011817:Rabbits; D013268:Stimulation, Chemical; D013997:Time Factors; D014599:Uterus / Q000187:drug effects*
D011453:Prostaglandins; D011374:Progesterone